Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hologic, Inc. (HOLX : NSDQ)
 
 • Company Description   
Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.

Number of Employees: 7,063

 
 • Price / Volume Information   
Yesterday's Closing Price: $66.38 Daily Weekly Monthly
20 Day Moving Average: 1,495,210 shares
Shares Outstanding: 222.42 (millions)
Market Capitalization: $14,764.19 (millions)
Beta: 0.57
52 Week High: $84.39
52 Week Low: $51.90
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.47% -4.23%
12 Week 3.77% -5.79%
Year To Date -7.92% -17.79%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
250 CAMPUS DRIVE
-
MARLBOROUGH,MA 01752
USA		 ph: 508-263-2900
fax: 781-890-8031		 michael.watts@hologic.com http://www.hologic.com
 
 • General Corporate Information   
Officers
STEPHEN P. MACMILLAN - Chief Executive Officer; Chairman and President
KARLEEN M. OBERTON - Chief Financial Officer
BENJAMIN J. COHN - Vice President and Corporate Controller
AMY M. WENDELL - Lead Independent Director
SALLY W. CRAWFORD - Director

Peer Information
Hologic, Inc. (ABMD)
Hologic, Inc. (DMDS)
Hologic, Inc. (CPWY.)
Hologic, Inc. (EQUR)
Hologic, Inc. (ECIA)
Hologic, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 436440101
SIC: 3844
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/03/25
Share - Related Items
Shares Outstanding: 222.42
Most Recent Split Date: 4.00 (2.00:1)
Beta: 0.57
Market Capitalization: $14,764.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.10 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.24 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 6.51% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/03/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 15.66
Trailing 12 Months: 15.99
PEG Ratio: 2.41
Price Ratios
Price/Book: 3.05
Price/Cash Flow: 12.07
Price / Sales: 3.66
EPS Growth
vs. Year Ago Period: 1.89%
vs. Previous Quarter: 4.85%
Sales Growth
vs. Year Ago Period: 1.23%
vs. Previous Quarter: 1.84%
ROE
06/30/25 - 19.69
03/31/25 - 19.71
12/31/24 - 19.72
ROA
06/30/25 - 10.82
03/31/25 - 10.87
12/31/24 - 10.94
Current Ratio
06/30/25 - 3.55
03/31/25 - 3.24
12/31/24 - 3.49
Quick Ratio
06/30/25 - 2.81
03/31/25 - 2.52
12/31/24 - 2.78
Operating Margin
06/30/25 - 23.60
03/31/25 - 23.83
12/31/24 - 24.04
Net Margin
06/30/25 - 13.79
03/31/25 - 13.83
12/31/24 - 18.42
Pre-Tax Margin
06/30/25 - 16.73
03/31/25 - 16.92
12/31/24 - 22.81
Book Value
06/30/25 - 21.77
03/31/25 - 20.73
12/31/24 - 21.15
Inventory Turnover
06/30/25 - 2.76
03/31/25 - 2.82
12/31/24 - 2.66
Debt-to-Equity
06/30/25 - 0.52
03/31/25 - 0.54
12/31/24 - 0.52
Debt-to-Capital
06/30/25 - 34.22
03/31/25 - 34.86
12/31/24 - 34.28
 

Powered by Zacks Investment Research ©